Psilocybin restrains activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms.

Autor: Conn K; Monash University, Department of Physiology, 26 Innovation Walk, Clayton, VIC, 3800, Australia.; Monash Biomedicine Discovery Institute, 23 Innovation Walk, Clayton, VIC, 3800, Australia., Milton LK; Monash University, Department of Physiology, 26 Innovation Walk, Clayton, VIC, 3800, Australia.; Monash Biomedicine Discovery Institute, 23 Innovation Walk, Clayton, VIC, 3800, Australia., Huang K; Monash University, Department of Physiology, 26 Innovation Walk, Clayton, VIC, 3800, Australia.; Monash Biomedicine Discovery Institute, 23 Innovation Walk, Clayton, VIC, 3800, Australia., Munguba H; Department of Biochemistry, Weill Cornell Medicine, New York, NY, 10065, USA., Ruuska J; University of Helsinki, Yliopistonkatu 4, 00100, Helsinki, Finland., Lemus MB; Monash University, Department of Physiology, 26 Innovation Walk, Clayton, VIC, 3800, Australia.; Monash Biomedicine Discovery Institute, 23 Innovation Walk, Clayton, VIC, 3800, Australia., Greaves E; Monash University, Department of Physiology, 26 Innovation Walk, Clayton, VIC, 3800, Australia.; Monash Biomedicine Discovery Institute, 23 Innovation Walk, Clayton, VIC, 3800, Australia., Homman-Ludiye J; Monash Micro Imaging, Monash University, 15 Innovation Walk, Clayton, VIC, 3800, Australia., Oldfield BJ; Monash University, Department of Physiology, 26 Innovation Walk, Clayton, VIC, 3800, Australia.; Monash Biomedicine Discovery Institute, 23 Innovation Walk, Clayton, VIC, 3800, Australia., Foldi CJ; Monash University, Department of Physiology, 26 Innovation Walk, Clayton, VIC, 3800, Australia. claire.foldi@monash.edu.; Monash Biomedicine Discovery Institute, 23 Innovation Walk, Clayton, VIC, 3800, Australia. claire.foldi@monash.edu.
Jazyk: angličtina
Zdroj: Molecular psychiatry [Mol Psychiatry] 2024 Oct; Vol. 29 (10), pp. 3291-3304. Date of Electronic Publication: 2024 Apr 27.
DOI: 10.1038/s41380-024-02575-9
Abstrakt: Psilocybin has shown promise for alleviating symptoms of depression and is currently in clinical trials for the treatment of anorexia nervosa (AN), a condition that is characterised by persistent cognitive inflexibility. Considering that enhanced cognitive flexibility after psilocybin treatment is reported to occur in individuals with depression, it is plausible that psilocybin could improve symptoms of AN by breaking down cognitive inflexibility. A mechanistic understanding of the actions of psilocybin is required to tailor the clinical application of psilocybin to individuals most likely to respond with positive outcomes. This can only be achieved using incisive neurobiological approaches in animal models. Here, we use the activity-based anorexia (ABA) rat model and comprehensively assess aspects of reinforcement learning to show that psilocybin (post-acutely) improves body weight maintenance in female rats and facilitates cognitive flexibility, specifically via improved adaptation to the initial reversal of reward contingencies. Further, we reveal the involvement of signalling through the serotonin (5-HT) 1 A and 5-HT2A receptor subtypes in specific aspects of learning, demonstrating that 5-HT1A antagonism negates the cognitive enhancing effects of psilocybin. Moreover, we show that psilocybin elicits a transient increase and decrease in cortical transcription of these receptors (Htr2a and Htr1a, respectively), and a further reduction in the abundance of Htr2a transcripts in rats exposed to the ABA model. Together, these findings support the hypothesis that psilocybin could ameliorate cognitive inflexibility in the context of AN and highlight a need to better understand the therapeutic mechanisms independent of 5-HT2A receptor binding.
(© 2024. The Author(s).)
Databáze: MEDLINE
Externí odkaz: